CLDX US Equity
Celldex Therapeutics, Inc.Health Care · In Vitro & In Vivo Diagnostic Substances · CIK 744218 · FY ends Dec 31$41.70
-0.09 (-0.22%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 7.6M |
| % of shares out | 9.7% |
| Days to cover | 7.6 |
| Δ vs 2026-07-15 | -0.5% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 7,627,081 | -0.5% | 1,001,184 | 7.6 |
| 2026-07-15 | 7,663,191 | -1.0% | 838,121 | 9.1 |
| 2026-06-30 | 7,738,673 | +6.1% | 1,799,211 | 4.3 |
| 2026-06-15 | 7,295,393 | +2.1% | 805,783 | 9.1 |
| 2026-05-29 | 7,144,877 | +0.2% | 665,613 | 10.7 |
| 2026-05-15 | 7,130,776 | -6.2% | 708,676 | 10.1 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
